Veeva Systems said that Ora, Inc., an ophthalmic contract research organization (CRO), has adopted the Veeva Vault Clinical Suite to unify its clinical systems and processes. This decision enables Ora to combine CTMS, eTMF, and study start-up applications on one platform to improve operational efficiency and visibility throughout its clinical trials. 

“We needed new technology to streamline clinical operations,” said Edward Leftin, manager of clinical information systems at Ora, Inc. “Veeva’s suite of unified clinical applications helps our study teams work more efficiently. Now we can manage information and end-to-end trial processes, from site activation to study closeout.”

Ora’s transition to a unified clinical environment started with Veeva Vault eTMF, helping clinical teams manage documents and processes in real-time as the TMF is generated, improving inspection readiness and reducing study close out time from weeks to days. 

“CROs are leading the industry-wide shift to unify clinical operations and build more collaborative, strategic partnerships with sponsors,” said Jennifer Goldsmith, senior vice president of Veeva Vault. “Ora is a great example of how the Veeva Vault Clinical Suite is helping break down system and process silos to improve study execution and quality.”

Vault CTMS, Vault eTMF, and Vault Study Startup are part of the Veeva Vault Clinical Suite, the industry’s first cloud platform that combines EDC, CTMS, eTMF, and study start-up to unify clinical data management and operations. Vault Clinical applications are now used by more than 170 customers, including eight of the top 20 biopharmaceutical companies deploying globally.